Transforming Early Detection of Pancreatic Cancer with AI
At Galen Health, we harness the power of artificial intelligence to pioneer breakthroughs in the early detection and prevention of pancreatic cancer, offering hope and saving lives.
About Us
Welcome to Galen Health, where we are putting a stop to pancreatic cancer.
We are dedicated to revolutionizing the early detection of pancreatic cancer through our cutting-edge AI platform, OncoSight. By leveraging advanced algorithms and the vast amounts of information in electronic health records (EHR), we aim to turn this deadly disease into a manageable condition.
Our Mission
Our mission is clear: to end pancreatic cancer.
We transform the landscape of early cancer detection, making it more accurate, accessible, and actionable.
Pancreatic cancer has a 5 year survival rate of just 9%. This is primarily because this disease lacks a screening test, so it is difficult to detect early on. As a result, over 50% of pancreatic cancer is diagnosed at late stage, when outcomes are poor.
Galen Health is committed to changing that, shifting the paradigm from late-stage reactive care to early-stage prevention and treatment.
The Challenge
Pancreatic cancer detection faces significant hurdles, often diagnosed at an advanced stage when treatment options are limited. The OncoSight platform is a reason for hope in this challenge. Its innovative, AI-driven approach continuously monitors patients, dramatically improving rates of early cancer detection and survival.
OncoSight is not just technology; it's a lifeline
The AI analyzes diverse data streams to pinpoint early warning signs of cancer, providing comprehensive and continuous monitoring for all patients.
Early detection. Early management. Lives saved.
Behind the Innovation
At the heart of OncoSight are state-of-the-art AI algorithms and high-performance computing technologies that continuously analyze patient health data, identifying patterns that could be early indicators of a growing tumor.
Rather than responding to cancer, our approach detects it early on, allowing healthcare providers to stop it entirely
Want to know more?
Contact us.
Reach out and let's put an end to pancreatic cancer.